• The status of zinc in the development of hepatocellular cancer: An important, but neglected, clinically established relationship
  • Abrogating G<sub>2</sub>/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma
  • Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin
  • Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model
  • All-<i>trans</i>-retinoic acid antagonizes the hedgehog pathway by inducing patched

The status of zinc in the development of hepatocellular cancer: An important, but neglected, clinically established relationship

Leslie C Costello and Renty B Franklin

Abrogating G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma

Paola Indovina, Eleonora Marcelli, Domenico Di Marzo, Nadia Casini, Iris Maria Forte, Francesca Giorgi, Luigi Alfano, Francesca Pentimalli and Antonio Giordano

Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin

Xing-qi Li, Zhi-gang Ouyang, Sheng-hua Zhang, Hong Liu, Yue Shang, Yi Li and Yong-su Zhen

Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model

Chunsheng Li, Ann-Marie Chacko, Jia Hu, Kosei Hasegawa, Jennifer Swails, Luigi Grasso, Wafik S El-Deiry, Nicholas Nicolaides, Vladimir R Muzykantov, Chaitanya R Divgi and George Coukos

All-trans-retinoic acid antagonizes the hedgehog pathway by inducing patched

Alexander M Busch, Fabrizio Galimberti, Kristen E Nehls, Monic Roengvoraphoj, David Sekula, Bin Li, Yongli Guo, James DiRenzo, Steven N Fiering, Michael J Spinella, David J Robbins, Vincent A Memoli, Sarah J Freemantle and Ethan Dmitrovsky

Current Issue

Cancer Biology & Therapy

July 2014

Volume 15, Issue 7

View current issue

About the cover image
Production of anti-GD2 targeted etoposide-loaded liposomes. The background figure is a transmission electron micrograph with negative staining of a monodisperse population of immunoliposomes. The sequence of immunoliposome production is described in the foreground and consists of ethanol-mediated liposome assembly and drug (green) loading (left), post-insertion of PEG2000-maleimide was used to produce PEG (red) decorated liposomes (center), and anti-GD2 monoclonal antibodies (blue) were sulfonated, purified, and incubated with the activated PEG-containing liposomes to produce immunoliposomes (right). For more information, see Brown et al., in this issue.

Recent Articles